A. Laitinen

3.3k total citations · 1 hit paper
34 papers, 2.5k citations indexed

About

A. Laitinen is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, A. Laitinen has authored 34 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 14 papers in Physiology and 8 papers in Molecular Biology. Recurrent topics in A. Laitinen's work include Asthma and respiratory diseases (13 papers), Respiratory and Cough-Related Research (7 papers) and Neuropeptides and Animal Physiology (7 papers). A. Laitinen is often cited by papers focused on Asthma and respiratory diseases (13 papers), Respiratory and Cough-Related Research (7 papers) and Neuropeptides and Animal Physiology (7 papers). A. Laitinen collaborates with scholars based in Finland, Sweden and United Kingdom. A. Laitinen's co-authors include L. A. Laitinen, Tari Haahtela, T Kava, Matti T. J. Heino, Matti Partanen, Antti Hervonen, Per Venge, Camilla Böckelman, Peter K. Jeffery and Caj Haglund and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Applied Physiology.

In The Last Decade

A. Laitinen

34 papers receiving 2.4k citations

Hit Papers

Damage of the Airway Epithelium and Bronchial Reactivity ... 1985 2026 1998 2012 1985 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Laitinen Finland 22 1.6k 1.2k 440 421 408 34 2.5k
G. Kunkel Germany 28 1.3k 0.8× 593 0.5× 303 0.7× 981 2.3× 417 1.0× 122 2.5k
Sanae Shimura Japan 26 867 0.5× 1.1k 0.9× 371 0.8× 140 0.3× 133 0.3× 104 2.0k
Mitsuko Kondo Japan 25 912 0.6× 1.1k 0.9× 349 0.8× 213 0.5× 96 0.2× 116 1.9k
Kenichi Tokuyama Japan 23 936 0.6× 778 0.6× 209 0.5× 298 0.7× 160 0.4× 121 1.7k
Sekiya Koyama Japan 28 716 0.4× 777 0.6× 415 0.9× 118 0.3× 120 0.3× 76 2.1k
Omar Tliba United States 31 1.3k 0.8× 596 0.5× 516 1.2× 135 0.3× 139 0.3× 58 2.4k
Shahin Sanjar United States 21 985 0.6× 679 0.6× 425 1.0× 218 0.5× 138 0.3× 64 1.8k
David Ramos‐Barbón Spain 27 1.1k 0.7× 751 0.6× 509 1.2× 156 0.4× 79 0.2× 65 2.3k
A. J. M. van Oosterhout Netherlands 20 869 0.5× 471 0.4× 385 0.9× 350 0.8× 65 0.2× 45 1.7k
D. B. Borson United States 23 1.1k 0.6× 746 0.6× 548 1.2× 73 0.2× 1.1k 2.6× 29 2.1k

Countries citing papers authored by A. Laitinen

Since Specialization
Citations

This map shows the geographic impact of A. Laitinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Laitinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Laitinen more than expected).

Fields of papers citing papers by A. Laitinen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Laitinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Laitinen. The network helps show where A. Laitinen may publish in the future.

Co-authorship network of co-authors of A. Laitinen

This figure shows the co-authorship network connecting the top 25 collaborators of A. Laitinen. A scholar is included among the top collaborators of A. Laitinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Laitinen. A. Laitinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laitinen, A., et al.. (2020). Transketolase-Like Protein 1 and Glucose Transporter 1 in Gastric Cancer. Oncology. 98(9). 643–652. 5 indexed citations
2.
Gramolelli, Silvia, Jaana Hagström, A. Laitinen, et al.. (2019). High tissue MMP14 expression predicts worse survival in gastric cancer, particularly with a low PROX1. Cancer Medicine. 8(16). 6995–7005. 14 indexed citations
3.
Tervahartiala, Taina, A. Laitinen, Arto Kokkola, et al.. (2018). High serum MMP-14 predicts worse survival in gastric cancer. PLoS ONE. 13(12). e0208800–e0208800. 28 indexed citations
4.
Laitinen, A., Jaana Hagström, Harri Mustonen, et al.. (2018). Positive cytoplasmic UCHL5 tumor expression in gastric cancer is linked to improved prognosis. PLoS ONE. 13(2). e0193125–e0193125. 21 indexed citations
5.
Laitinen, A., Camilla Böckelman, Jaana Hagström, et al.. (2017). High PROX1 expression in gastric cancer predicts better survival. PLoS ONE. 12(8). e0183868–e0183868. 16 indexed citations
6.
Laitinen, A., Camilla Böckelman, Jaana Hagström, et al.. (2015). Podocalyxin as a Prognostic Marker in Gastric Cancer. PLoS ONE. 10(12). e0145079–e0145079. 23 indexed citations
7.
Laitinen, A. & Mikko Niemi. (2010). Frequencies of Single-Nucleotide Polymorphisms of SLCO1A2, SLCO1B3 and SLCO2B1 Genes in a Finnish Population. Basic & Clinical Pharmacology & Toxicology. 108(1). 9–13. 28 indexed citations
8.
Piirilä, Päivi, Anneli Lauhio, Marja‐Leena Majuri, et al.. (2009). Matrix metalloproteinases‐7, ‐8, ‐9 and TIMP‐1 in the follow‐up of diisocyanate‐induced asthma. Allergy. 65(1). 61–68. 14 indexed citations
9.
Piirilä, Päivi, Marja‐Leena Majuri, Ritva Luukkonen, et al.. (2008). Inflammation and functional outcome in diisocyanate‐induced asthma after cessation of exposure. Allergy. 63(5). 583–591. 26 indexed citations
10.
Karjalainen, Eeva-Maija, Ari Lindqvist, L. A. Laitinen, et al.. (2003). Airway inflammation and basement membrane tenascin in newly diagnosed atopic and nonatopic asthma. Respiratory Medicine. 97(9). 1045–1051. 45 indexed citations
11.
Altraja, Alan, et al.. (1999). Regular albuterol or nedocromil sodium — effects on airway subepithelial tenascin in asthma. Respiratory Medicine. 93(7). 445–453. 7 indexed citations
12.
Virtanen, Ismo, A. Laitinen, Taneli Tani, et al.. (1996). Differential Expression of Laminins and Their Integrin Receptors in Developing and Adult Human Lung. American Journal of Respiratory Cell and Molecular Biology. 15(2). 184–196. 74 indexed citations
13.
Altraja, Alan, A. Laitinen, Ismo Virtanen, et al.. (1996). Expression of Laminins in the Airways in Various Types of Asthmatic Patients: A Morphometric Study. American Journal of Respiratory Cell and Molecular Biology. 15(4). 482–488. 89 indexed citations
14.
Haahtela, Tari, A. Laitinen, & L. A. Laitinen. (1993). Using biopsies in the monitoring of inflammation in asthmatic patients. Allergy. 48(s17). 65–69. 7 indexed citations
15.
Laitinen, L. A. & A. Laitinen. (1991). 1. PATHOLOGY OF HUMAN ASTHMA. 41(8). 1001. 6 indexed citations
16.
Heino, Matti T. J., Jouko Karjalainen, Jukka Ylikoski, A. Laitinen, & L. A. Laitinen. (1988). Bronchial ciliogenesis and oral steroid treatment in patients with asthma. British Journal of Diseases of the Chest. 82(2). 175–178. 13 indexed citations
17.
Laitinen, L. A., A. Laitinen, Raimo O. Salonen, & J. G. Widdicombe. (1987). Vascular Actions of Airway Neuropeptides. American Review of Respiratory Disease. 136(6_pt_2). S59–S64. 40 indexed citations
18.
Laitinen, L. A., Matti T. J. Heino, A. Laitinen, T Kava, & Tari Haahtela. (1985). Damage of the Airway Epithelium and Bronchial Reactivity in Patients with Asthma. American Review of Respiratory Disease. 131(4). 599–606. 1043 indexed citations breakdown →
19.
Laitinen, A.. (1985). Autonomic innervation of the human respiratory tract as revealed by histochemical and ultrastructural methods.. PubMed. 140. 1–42. 18 indexed citations
20.
Haahtela, Tari, et al.. (1983). Non-specific bronchial reactivity and ultrastructure of the airway epithelium in patients with sarcoidosis and allergic alveolitis.. PubMed. 131. 267–84. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026